Mapping interactions foundational to therapeutic discovery and human health.
Kanvas Biosciences has raised $48.0M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Kanvas Biosciences's investors include Gaingels, Alumni Ventures, Mana Ventures, Bill & Melinda Gates Foundation, DCVC.
Kanvas Biosciences is headquartered in Monmouth Junction, United States.
Mapping interactions foundational to therapeutic discovery and human health.
Kanvas Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kanvas Biosciences — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/kanvas-biosciences. Accessed July 19, 2026.
VCBacked. (2026). Kanvas Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/kanvas-biosciences
{{cite web |title=Kanvas Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/kanvas-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated